Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Sep 24;18(1):253.
doi: 10.1186/s12957-020-02032-1.

Major complications of post-chemotherapy retroperitoneal lymph node dissection in a contemporary cohort of patients with testicular cancer and a review of the literature

Affiliations
Review

Major complications of post-chemotherapy retroperitoneal lymph node dissection in a contemporary cohort of patients with testicular cancer and a review of the literature

Christian Guido Ruf et al. World J Surg Oncol. .

Abstract

Background: Post-chemotherapy retroperitoneal lymph node dissection (pc-RPLND) is one cornerstone in the clinical management of patients with nonseminomatous testicular germ cell tumours (GCT). A wide range of complication rates in this type of surgery is reported so far. We retrospectively evaluated the frequency of major complications by using the Clavien-Dindo classification and analysed the influence of various clinical factors on complication rates in pc-RPLND.

Methods: We retrospectively analysed 146 GCT patients undergoing pc-RPLND. Complications of grade III-V according to the Clavien-Dindo classification occurring within 30 days after surgery were registered along with the following clinical factors: age, body mass index (BMI), duration of surgery, number of anatomic fields resected, side of primary tumour, histology of surgical specimen, histology of primary tumour, and total dose of cisplatin applied prior to surgery. For comparison, we also evaluated 35 chemotherapy-naïve patients with primary RPLND and 19 with laparoscopic RPLND. We analysed types and frequencies of the various complications as well as associations with clinical factors using descriptive statistical methods.

Results: A total of 14.4% grade III-IV complications were observed in pc-RPLND, and 8.6% and 5.3% in primary and in laparoscopic RPLND, respectively. There was no perioperative mortality. Lymphocele was the most frequent adverse event (16% of grade III-IV complications). Operation time > 270 min (p = 0.001) and vital cancer in the resected specimen (p = 0.02) were significantly associated with higher complication rates. Left-sided resection fields involved two-fold higher complication rates, barely missing statistical significance (p = 0.06).

Conclusions: Pc-RPLND involves a grade III-V complication rate of 14.4%. Prolonged operation time and vital cancer in the residual mass are significantly associated with higher complication rates. The Clavien-Dindo classification system may allow inter-observer variation in rating complication grades, which may represent one reason for the wide range of reported RPLND complication rates. RPLND represents major surgery and surgeons active in this field must be competent to manage adverse events.

Keywords: Lymphocele; Nonseminoma; Retroperitoneal lymph node dissection; Surgical complication; Testicular germ cell tumour.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Left-sided multi-chambered intraabdominal lymphocele arising after post-chemotherapy RPLND. Magnetic resonance imaging, T2-weighted imaging, coronal sectioning. This lymphocele resolved spontaneously within 3 months

Comment in

Similar articles

Cited by

References

    1. Hanna NH, Einhorn LH. Testicular cancer - discoveries and updates. N Engl J Med. 2014;371:2005–2016. doi: 10.1056/NEJMra1407550. - DOI - PubMed
    1. Rajpert-De Meyts E, McGlynn KA, Okamoto K, Jewett MA, Bokemeyer C. Testicular germ cell tumours. Lancet. 2016;387:1762–1774. doi: 10.1016/S0140-6736(15)00991-5. - DOI - PubMed
    1. Kocher T. Die Krankheiten der männlichen Geschlechtsorgane. Stuttgart: Ferdinand Enke Verlag; 1887. §1006; pp. 491–492.
    1. Donohue JP. Evolution of retroperitoneal lymphadenectomy (RPLND) in the management of non-seminomatous testicular cancer (NSGCT) Urol Oncol. 2003;21:129–132. doi: 10.1016/S1078-1439(02)00212-0. - DOI - PubMed
    1. Heidenreich A, Paffenholz P, Nestler T, Pfister D. Primary and postchemotherapy retroperitoneal lymphadenectomy for testicular cancer. Oncol Res Treat. 2018;41:370–378. doi: 10.1159/000489508. - DOI - PubMed

MeSH terms